Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OP0201 in Infants and Children with Acute Otitis Media
NCT03818815Phase 2Completed
- Sponsor
- Eledon Pharmaceuticals, Inc.
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute otitis media (AOM) comparing OP0201 + Antibiotics with Placebo + Antibiotics (2 arms). Primary endpoints: Number of Participants With Adverse Events, Evaluation of Efficacy (Otoscopy) - Resolution of Bulging Tympanic Membrane at Day 4 and 1 more. Started Feb 2019; status: completed.
02
Drugs
OP0201
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT03818815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818815.